(Q36511673)

14 August 2017

1 reference

title

Contribution of allelic variations in transporters to the phenotype of drug response (English)

1 reference

14 August 2017

1 reference

3

Edgar Schömig

1 reference

14 August 2017

2

Dirk Gründemann

1 reference

14 August 2017

Julia Kirchheiner

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Journal of Psychopharmacology

14 August 2017

published in

1 reference

14 August 2017

volume

20

1 reference

14 August 2017

issue

4 Suppl

1 reference

14 August 2017

page(s)

27-32

1 reference

Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Genetic variants of the serotonin system and weight change during clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Antipsychotics and dopamine transporter gene polymorphisms in delirium patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Serotonin transporter: gene, genetic disorders, and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Human Dopamine Transporter Gene Not Linked to Schizophrenia in Multigenerational Pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066043

21 January 2018

Identifiers

DOI

10.1177/1359786806066043

1 reference

14 August 2017

1 reference